Eupraxia pharmaceuticals inc EPRX.US 總覽分析

EPRX 投資分析

EPRX 近期報酬表現

與 EPRX 同產業的標的表現

• EXEL Exelixis, inc.

  價值 4 分趨勢 4 分波段 4 分籌碼 4 分股利 1 分

  查看更多
• QNCX Quince therapeutics inc
• ROIV Roivant sciences ltd
• GLUE Monte rosa therapeutics inc
• ALT Altimmune inc
• MIST Milestone pharmaceuticals inc
• SLDB Solid biosciences inc
• TERN Terns pharmaceuticals inc
• SYBX Synlogic inc
• NAGE Niagen bioscience inc

EPRX 公司資訊

Eupraxia Pharmaceuticals Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on the development of locally delivered, extended-release products. The Company's lead product candidate, EP-104, is designed to address the significant unmet medical need and market demand for conditions where long-lasting symptom relief is essential to effective treatment. The primary targets for EP-104 have been identified as knee osteoarthritis (OA) and eosinophilic esophagitis (EoE). The product in development for OA is called EP-104IAR and the product in development in EoE is called EP-104GI. DiffuSphere, a proprietary, polymer based micro-sphere technology, is designed to facilitate targeted drug delivery, with extended duration of effect, and offers multiple, highly tunable pharmacokinetic (PK) profiles.